PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION
Clinical trials for PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION trials appear
Sign up with your email to follow new studies for PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on lupus, scleroderma, and Sjogren's
Disease control Recruiting nowThis study tests a new treatment using a patient's own immune cells, modified to target and attack harmful cells in three severe autoimmune diseases: lupus nephritis, systemic sclerosis, and Sjogren's syndrome with pulmonary hypertension. About 45 adults will receive a single inf…
Matched conditions: PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could CAR-T cells tame tough autoimmune diseases?
Disease control Recruiting nowThis early-stage trial is testing a new treatment made from umbilical cord blood cells, called CD19-BCMA CAR-T cells, in 45 people with severe lupus, scleroderma, or Sjogren's syndrome with lung complications. The main goal is to check safety, especially serious side effects with…
Matched conditions: PRIMARY SJOGREN'S SYNDROME COMBINED WITH PULMONARY HYPERTENSION
Phase: PHASE1, PHASE2 • Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC